Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2006-01-31
2006-01-31
Berch, Mark L. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S262000, C544S263000, C544S276000, C544S278000, C544S350000, C546S114000, C546S115000, C546S117000, C546S118000, C546S119000, C546S121000
Reexamination Certificate
active
06992188
ABSTRACT:
Corticotropin-releasing factor (CRF) antagonists having the formulawherein the dashed lines, A, B, D E, F, Z, G, R3, and R5having the definitions set forth in the specification pharmaceutical compositions containing them.
REFERENCES:
patent: 4605642 (1986-08-01), Rivier et al.
patent: 4725601 (1988-02-01), Ueda et al.
patent: 4904666 (1990-02-01), Friebe et al.
patent: 5028605 (1991-07-01), Sablayrolles et al.
patent: 5063245 (1991-11-01), Abreu et al.
patent: 5223540 (1993-06-01), Wurtman et al.
patent: 5464872 (1995-11-01), Langlois et al.
patent: 5541054 (1996-07-01), Miller et al.
patent: 5561134 (1996-10-01), Spada et al.
patent: 5597826 (1997-01-01), Howard et al.
patent: 5710168 (1998-01-01), Chenard
patent: 5744501 (1998-04-01), Norden
patent: 5776969 (1998-07-01), James
patent: 5795895 (1998-08-01), Anchors
patent: 5852031 (1998-12-01), Desai et al.
patent: 6552192 (2003-04-01), Hanus et al.
patent: 2005/0038049 (2005-02-01), Ding et al.
patent: 2005/0107343 (2005-05-01), Kasibhatia et al.
patent: 0157637 (1985-10-01), None
patent: WO9413676 (1994-06-01), None
patent: WO9413677 (1994-06-01), None
patent: WO9533750 (1995-12-01), None
patent: WO9534563 (1995-12-01), None
patent: WO9911643 (1999-03-01), None
Bisagni, J Org Chem 47, 1500.
Jorgensen, Chem Abs 102, 78815 (1984).
Traxler, J Med Chem 39, 2285 (1996).
Chalmers, TiPS 17(4), 166, 1996.
Stratakis, Endocrinology: Basic and Clinical Principles (Humana Press, Totowa NJ), p185-209, 1997.
DeVita, ed, “Cancer: Principles & Practices of Oncology, 5th Edition”, index pp. 24-25, 1997.
Peckam, ed., Oxford Textbook of Oncology, vol. 1, p. 452, 1995.
Foster, “Syndrome of Inapproproiate Antidiuretic Hormone” http://www.emedicine.com/emerg/topic784.htm, 1997.
The American Heritage College Dictionary (Houghton Mifflin Company USA; 1993), p. 1105 and p. 399.
Physicians's Desk Reference 52ed (Medical Economics Company, Inc., USA, 1998) pp. 472-474.
REVIA (naltrexone HCI), pp. 1-15, Dupont Pharma 1995 (www.dupontmerk.com).
Owens, M.J., and Nerneroff, C.B., Pharm. Rev., vol. 43, No. 4, 425-473 (1991).
Strijbos, P.J.L.M., et al., Brain Res. 656, pp. 405-408 (1994).
Lyons, M.K., et al., Brain Res. 545, pp. 339-342 (1991).
Fackelmann, K.A., and Raloff, J., Psycholgical Stress Linked to Cancer, Science News, (Sep. 25, 1993) vol. 144, p. 196.
Suda. et al., The role of corticotropin-releasing factor and vasopressin in hypoglycemia-induced pro-opiomelanocortin gene expression in the rat anterior pituitary gland, Brain Res. (1992), 579(2), pp. 303-308.
Sheharu, S. et al., Peripheral plasma corticortropin-releasing hormone (CHR) in an aged patient with fasting hypoglycemia associated with an insufficient secretion of insulin. An implication of plasma CRH in glucose metabolism, Nippon Naibunpi Gakkai Zasshi (1995), 71(5), pp. 659-672.
Reversibility of Physiological Growth Hormone Secretion in Children with Psychosocial Dwarfism, A. Albanese, et al., Clinical Endocrinology (1994) 40, pp. 687-692.
Psychosocial Dwarfism: Identification, Intervention and Planning, Bowden M. L.; Hopwood NJ Soc. Work Health Care (United States), Spring 1982, 7 (3) pp. 15-36.
Recent Advances in Antiviral Therapy, Kinchington D., J Clin Pathol, Feb. 1999, 52 (2) pp. 89-94.
The Role of Serotonin in Craving: From Basic Research to Human Studies, Ciccocioppo R., Alcohol & Alcoholism, vol. 34, No. 2, pp. 244-253, 1999.
EMBASE abstract No. 97225140 of Kapelle et al. (Kapelle et al., Pharmaceutisch Weekblad, (1997)).
Berch Mark L.
Ladas & Parry LLP
Pfizer Inc.
LandOfFree
Substituted heterocyclic derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heterocyclic derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3552028